The annual Awards of Excellence Ceremony is held yearly at the Bleeding Disorders Conference.PHYSICIAN OF THE YEAR(Named in honor of Dr. Kenneth Brinkhous)2024 Mark Reding, MD 2023 Doris Quon, MD2022 Dr. Kimo Stine2021 Miguel…
The Plasma Protein Therapeutics Association (PPTA) recently posted an online update that addresses safety concerns relevant to the recent monkeypox virus (MPXV) outbreak and plasma protein therapies.
According to the new statement, while…
The 2022 Bleeding Disorders Conference has kicked off with first issue of the NHF Show Daily!
Read it now
The European Commission granted conditional approval to BioMarin's Hemophilia A gene therapy Valoctocogene Roxaparvovec which will be known as Roctavian.With this approval in Europe the regulators will monitor the use of Valrox for 15 years to…
Dr. Tam E. Perry is an associate professor at Wayne State University School of Social Work. Her research addresses urban aging from a life course perspective, focusing on how underserved older adults navigate their social and built environments in…
Get the latest news from the 2022 Bleeding Disorders Conference with Friday issue of the NHF Show Daily!Read it now
Get the latest news from the 2022 Bleeding Disorders Conference with the Saturday issue of the NHF Show Daily!Read it now
Aug 28, 2022 FOR IMMEDIATE RELEASE MEDIA CONTACT Ilana Ostrin Senior Director of Public Relations and Communications …
Get the latest news from the 2022 Bleeding Disorders Conference with the Wrap-up issue of the NHF Show Daily!Read it now
A newly released survey of individuals with Hereditary Factor X Deficiency (HFXD) and caregivers of those with HFXD yielded noteworthy insights related to treatment and quality of life (QoL).
The initial data gleaned from HFXD American Survey…